Press Releases AVROBIO, Inc.

Equities

AVRO

US05455M1009

Delayed Nasdaq Other stock markets 12:04:16 2024-04-30 pm EDT			5-day change	1st Jan Change
1.21 ^USD	+1.68%		0.00%	-11.03%

Mar. 21	North American Morning Briefing : Investors -2-	DJ
Mar. 14	AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure	Mar. 27	AQ
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO	Feb. 14	BU
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonic	Jan. 31	PR
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders	Jan. 30	BU
AVROBIO and Tectonic Therapeutic Announce Merger	Jan. 30	BU
AVROBIO to Explore Strategic Alternatives	23-07-12	BU
AVROBIO : UNAUDITED PRO FORMA FINANCIAL INFORMATION - Form 8-K	23-06-12	PU
AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million	23-06-12	BU
BigTime Penny Stocks: Rapid Growth in Gene Therapy Market (GNPX, LEAS;RWOD, VYGR, AVRO)	23-06-01	AQ
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million	23-05-22	BU
AVROBIO : ASGCT Cystinosis Update May 2023	23-05-18	PU
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26th Annual Meeting	23-05-18	BU
AVROBIO, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update	23-05-11	BU
AVROBIO, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-01	AQ
AVROBIO Announces Leadership Transition	23-05-01	BU
AVROBIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-23	AQ
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update	23-03-23	BU
AVROBIO to Participate in Cowen's 43rd Annual Health Care Conference	23-03-06	AQ
AVROBIO : Investor Presentation March 2023	23-03-06	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AVROBIO, Inc.

Equities

AVRO

US05455M1009

Press Releases

Filters